Veronique Lecault, Chief Operating Officer at AbCellera Biologics Inc. (ABCL), bought 200,000 shares at $6.34 ($1.3M) on 2022-05-16, disclosed to the SEC on 2022-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ABCL | SELL | 2021-06-10 | $25.5M | — | Filing → |
| ABCL | BUY | 2020-12-17 | $460K | — | Filing → |